Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 56,900 shares, an increase of 341.1% from the October 31st total of 12,900 shares. Based on an average daily volume of 154,600 shares, the short-interest ratio is presently 0.4 days.
Merck KGaA Stock Up 0.6 %
Shares of MKKGY traded up $0.18 during mid-day trading on Wednesday, reaching $29.86. The company had a trading volume of 80,110 shares, compared to its average volume of 69,244. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a 50-day moving average price of $33.21 and a 200 day moving average price of $34.93. Merck KGaA has a 52 week low of $28.96 and a 52 week high of $39.17. The company has a market capitalization of $19.30 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 2.32 and a beta of 0.96.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group started coverage on Merck KGaA in a report on Thursday, September 19th. They set a “buy” rating on the stock.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 3 Stocks to Consider Buying in October
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is an Earnings Surprise?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Transportation Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.